Gastroenterology Research, ISSN 1918-2805 print, 1918-2813 online, Open Access
Article copyright, the authors; Journal compilation copyright, Gastroenterol Res and Elmer Press Inc
Journal website https://gr.elmerpub.com

Original Article

Volume 17, Number 5-6, December 2024, pages 205-211


Evaluating the Impact of Phosphatidylethanol Testing on Hospital Outcomes

Figure

Figure 1.
Figure 1. Analysis of patient breakdown.

Tables

Table 1. Patient Characteristics
 
VariablePositive PEth (total number of patients)Negative PEth (total number of patients)
PEth: phosphatidylethanol.
Mean age (years)54.447.4
Female1,9081,388
Male3,0741,296
Hispanic or Latino262240
White3,4551,092
Black906836
Asian66114
Other293402

 

Table 2. Patient Outcomes
 
OutcomePositive PEth results (≥ 20 ng/mL) (patient total)Negative PEth results (≤ 19 ng/mL) (patient total)95% CIP-value
CI: confidence interval; ICU: intensive care unit; PEth: phosphatidylethanol.
Mortality251 deaths286.759 - 14.906< 0.001
Delirium tremens17 cases0 casesN/A (low cell size)N/A
Endoscopy/colonoscopy463 procedures118 procedures3.836 - 5.866< 0.001
Liver transplant listing185 patients112 patients1.345 - 2.186< 0.001
Liver transplant rejection22 cases10 cases1.045 - 4.6840.033
Liver transplant complications56 cases20 cases1.704 - 4.764< 0.001
Hepatorenal syndrome84 cases16 cases3.168 - 9.293< 0.001
ICU admission318 admissions10 admissions19.78 - 70.09< 0.0001
Hepatic encephalopathy205 cases151 cases1.121 - 1.7390.003
Sarcopenia31 cases10 cases1.531 - 6.4030.001